Patritumab deruxtecan (Synonyms:HER3-DXd)
目录号 : KM38646 CAS No. : 2227102-46-5 纯度 : 99%
Patritumab deruxtecan (HER3-DXd) 是一种抗体-活性分子偶联物 (ADC),由全人抗 HER3 IgG1 单克隆抗体 Patritumab 通过基于四肽的可裂解接头连接到拓扑异构酶 I 抑制剂有效载荷组成 。
规格 价格 是否有货 数量
1mg
In-stock
5mg 询价 In-stock
10mg 询价 In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性
Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity.
分子量
155238 (average)
CAS号
2227102-46-5
运输条件
Shipping with dry ice.
储存方式
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2